Mahamaya Lifesciences
add_icon

Mahamaya Lifesciences

191.50
-3.50
(-1.79%)
Market Cap
448.21 Cr
PE Ratio
35.26
Volume
1,50,000.00
Day High - Low
198.00 - 191.00
52W High-Low
205.05 - 111.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
448.21 Cr
EPS
7.60
PE Ratio
35.26
PB Ratio
4.01
Book Value
48.77
EBITDA
26.00
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
26.19
Debt to Equity
1.52
Forecast For
Actual

Company News

View All News
Caret
positive
Mahamaya Lifesciences Limited received the prestigious 'Company of the Year – Medium Scale' award at ICSCE 2026 in Dubai, organized by PMFAI on January 20, 2026.
positive
Prominent investor Vijay Kedia acquired 8.91 lakh shares of Mahamaya Lifesciences at ₹140 per share, signaling confidence in the SME-listed agro chemicals company.
positive
Mahamaya Lifesciences Limited approved unaudited financial results for half-year ended September 30, 2025, showing revenue from operations of Rs 16,306.37 lakhs compared to Rs 14,623.12 lakhs in the same period last year. The agricultural crop protection solutions company reported standalone profit of Rs 852.56 lakhs with earnings per share of Rs 4.80, reflecting strong operational performance in the first half.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
741.30
#1 62,515.22
31.49
#1 47,123.00
8.13
820
-42.56
50.36
3,129.30
47,477.15
31.50
8,322.00
5.70
#1 1,660
-19.46
42.63
410.35
20,482.45
39.37
3,268.60
11.19
506
-13.27
40.02
4,489.90
20,178.55
32.96
5,593.10
7.89
568
12.03
55.53
1,192.30
10,756.99
18.57
4,379.40
#1 35.89
304
#1 366.56
77.28
270.65
5,263.30
31.33
2,631.40
6.54
164
-274.07
54.27
1,051.00
4,737.73
#1 16.24
2,071.30
15.49
297
27.97
37.01
136.13
3,185.62
-74.00
1,242.60
-30.48
-92
71.82
36.11
1,828.60
3,039.33
23.24
1,199.00
12.53
141
-13.08
41.37
227.61
2,951.40
240.32
449.80
9.63
14
1.85
56.72
Growth Rate
Revenue Growth
64.13 %
Net Income Growth
148.08 %
Cash Flow Change
102.29 %
ROE
23.77 %
ROCE
11.19 %
EBITDA Margin (Avg.)
9.09 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Revenue
0
120
Expenses
0
108
EBITDA
0
12
Operating Profit %
0 %
8 %
Depreciation
0
1
Interest
0
3
Profit Before Tax
0
7
Tax
0
2
Net Profit
0
6
EPS in ₹
0.00
3.11

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
56
78
112
188
Fixed Assets
20
21
22
27
Current Assets
33
54
87
157
Capital Work in Progress
2
2
3
4
Investments
0
0
0
0
Other Assets
34
54
88
157
Total Liabilities
56
78
112
188
Current Liabilities
30
48
78
132
Non Current Liabilities
10
11
9
7
Total Equity
16
19
25
49
Reserve & Surplus
15
18
23
32
Share Capital
1
1
1
18

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
1
-0
1
Investing Activities
-3
-3
-2
-8
Operating Activities
2
1
-23
1
Financing Activities
1
2
24
9

Share Holding

% Holding
Feb 2025
Oct 2025
Nov 2025
Promoter
77.27 %
77.27 %
56.35 %
FIIs
0.00 %
0.00 %
6.39 %
DIIs
0.00 %
0.00 %
4.67 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
12.72 %
Others
22.73 %
22.73 %
19.88 %
No of Share Holders
18
18
1,034

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Dec 2025 116.35 115.55

Technical Indicators

RSI(14)
Neutral
62.02
ATR(14)
Less Volatile
8.52
STOCH(9,6)
Overbought
84.85
STOCH RSI(14)
Overbought
96.22
MACD(12,26)
Bullish
1.40
ADX(14)
Strong Trend
34.78
UO(9)
Bearish
56.88
ROC(12)
Uptrend And Accelerating
14.88
WillR(14)
Overbought
-14.64